Cynata Therapeutics Ltd
XBER:51S
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cynata Therapeutics Ltd
XBER:51S
|
AU |
|
A
|
Arctic Bioscience AS
F:9TD
|
NO |
|
M
|
Moss Genomics Inc
CNSX:MOSS
|
CA |
|
CleanTech Alpha Corp
OTC:GERS
|
US |
|
T
|
Tycoons Worldwide Group Thailand PCL
SET:TYCN
|
TH |
|
M
|
MyTech Group Bhd
KLSE:MYTECH
|
MY |
Shareholder Yield
Current shareholder yield for
51S is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
51S Price
Cynata Therapeutics Ltd
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown |
N/A
|
| Market Capitalization | 2.8m EUR |
| Shares Outstanding | 143 276 594 |
| Percentage of Shares Shorted |
N/A
|
51S Return Decomposition
Main factors of price return
Stock Splits
51S's latest stock split occurred on Oct 31, 2013
The company executed a 1-for-20 stock split, meaning that for every 20 shares held, investors received 1 new share.
Before the split, 51S traded at 0.014 per share. Afterward, the share price was about 0.014.
The adjusted shares began trading on Oct 31, 2013. This was the only stock split in 51S's history.